PLIVA d.d
As a result of the PLIVA acquisition, Barr operates
in more than 30 countries around the world through PLIVA d.d. and its subsidiaries (PLIVA). Under the PLIVA
name, Barr markets more than 1,025 branded generic products that compete in the key markets of Croatia, Germany,
Poland and Russia, and includes solid dose forms, injectables, creams/ointments, over-the-counter (OTC) products,
cytostatics, and active pharmaceutical ingredients (APIs).
Operations are primarily in Central and Eastern Europe,
including Croatia, Germany, Poland and Russia. These markets vary considerably from the U.S. market in that in
many cases there is a market for "branded-generic" products (i.e., generic products sold under a company name)
for which there are only limited opportunities for generic substitution by a pharmacist. As a result, physician
and pharmacist loyalty to a particular company's generic product can be a significant driver in obtaining market share.
Product Guide 
